- I-Mab Biopharma press release (NBP): 1H GAAP EPS of -$0.33.
- As of June 30, 2026, the company had cash, cash equivalents, short-term investments, and equity investment at fair value of $215.9 million.
- Based on its current operating plan, the Company believes
